Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.42 |
| ▸ | ESR1 | P03372 | 4/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | MYC | P01106 | 1/20 | 0.41 |
| ▸ | MAX | P61244 | 1/20 | 0.41 |
| ▸ | PLAU | P00749 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14077239 | 0.92 | ALDH1A1 (0.54) | KDM4EALDH1A1HPGDENPP2MEN1 | |
| SCHEMBL2368334 | 0.92 | ALDH1A1 (0.54) | KDM4EALDH1A1HPGDENPP2MEN1 | |
| SCHEMBL30928218 | 0.85 | NQO2 (0.56) | KDM4EALDH1A1HPGDENPP2MEN1 | |
| SCHEMBL2367791 | 0.85 | NQO2 (0.56) | KDM4EALDH1A1HPGDENPP2MEN1 | |
| SCHEMBL6204931 | 0.85 | NQO2 (0.48) | KDM4EALDH1A1HPGDENPP2MEN1 | |
| SCHEMBL14582918 | 0.82 | ALDH1A1 (0.50) | KDM4EALDH1A1HPGDENPP2MEN1 | |
| SCHEMBL9979780 | 0.81 | MAPT (0.46) | KDM4EALDH1A1HPGDMEN1KMT2A | |
| SCHEMBL22529583 | 0.79 | KDM4E (0.64) | KDM4EALDH1A1HPGDENPP2MEN1 | |
| SCHEMBL21497957 | 0.79 | ALDH1A1 (0.43) | KDM4EALDH1A1HPGDENPP2MEN1 | |
| SCHEMBL22546201 | 0.79 | KDM4E (0.64) | KDM4EALDH1A1HPGDENPP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250228880-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2025-07-17 | — | — | US | disclosed |
| US-20230411662-A1 | Electrolyte Regeneration for Organic Redox Flow Batteries Based on Water-Soluble Phenzaine-Based Compounds | CMBLU ENERGY AG (DE) | 2023-12-21 | — | — | US | disclosed |
| EP-4252295-A1 | ELECTROLYTE REGENERATION FOR ORGANIC REDOX FLOW BATTERIES BASED ON WATER-SOLUBLE PHENAZINE-BASED COMPOUNDS | CMBlu Energy AG (DE) | 2023-10-04 | — | — | EP | disclosed |
| US-11421223-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2022-08-23 | — | — | US | disclosed |
| WO-2022111833-A1 | ELECTROLYTE REGENERATION FOR ORGANIC REDOX FLOW BATTERIES BASED ON WATER-SOLUBLE PHENAZINE-BASED COMPOUNDS | CMBLU ENERGY AG (DE) | 2022-06-02 | — | — | WO | disclosed |
| WO-2022111833-A1 | ELECTROLYTE REGENERATION FOR ORGANIC REDOX FLOW BATTERIES BASED ON WATER-SOLUBLE PHENAZINE-BASED COMPOUNDS | CMBLU ENERGY AG (DE) | 2022-06-02 | — | — | WO | disclosed |
| US-20190309289-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2019-10-10 | — | — | US | disclosed |
| US-10370654-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. (US) | 2019-08-06 | — | — | US | disclosed |
| US-20180320170-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2018-11-08 | — | — | US | disclosed |
| US-9944925-B2 | Processes and host cells for genome, pathway, and biomolecular engineering | ENEVOLV, INC. | 2018-04-17 | — | — | US | disclosed |
| US-20170266215-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2017-09-21 | — | — | US | disclosed |
| US-20160186168-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. | 2016-06-30 | — | — | US | disclosed |
| EP-3027754-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | enEvolv, Inc. (US) | 2016-06-08 | — | — | EP | disclosed |
| WO-2015017866-A1 | PROCESSES AND HOST CELLS FOR GENOME, PATHWAY, AND BIOMOLECULAR ENGINEERING | ENEVOLV, INC. (US) | 2015-02-05 | — | — | WO | disclosed |
| US-20100124554-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2010-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228880-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | TXN2, SQOR, LPO | KDM4E 3013/4885ALDH1A1 720/4885HPGD 175/4885 |
| US-20100124554-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | TXN2, SQOR, LPO | KDM4E 3013/4885ALDH1A1 720/4885HPGD 175/4885 |
| US-20170266215-A1 | REDOX-ACTIVE COMPOUNDS AND RELATED COMPOUNDS, COMPOSITIONS, METHODS AND SYSTEMS | TXN2, SQOR, LPO | KDM4E 3013/4885ALDH1A1 720/4885HPGD 175/4885 |
| US-20230411662-A1 | Electrolyte Regeneration for Organic Redox Flow Batteries Based on Water-Soluble Phenzaine-Based Compounds | SLC6A12, POF1B, GPX4 | KDM4E 1389/4885ALDH1A1 372/4885HPGD 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.